[The use of monosodium glutamate in the combined therapy of patients with atrophic gastritis].
Monosodium glutamate (MSG) taken per os has been found to stimulate gastric secretion provoked by pentagastrin. MSG gave rise to a marked elevation of endogenic gastrin levels both in experimental animals and atrophic gastritis patients. Thirty-six patients with secretory gastric insufficiency received MSG as an additive to their food during combined therapy of their disease. The preparation proved to be well-tolerated, good stimulant of gastric secretion, efficient in digestion improvement. MSG is recommended as an adjuvant in combined therapy of atrophic gastritis.
Kochetkov
A M
AM
Shlygin
G K
GK
Loranskaia
T I
TI
Vasilevskaia
L S
LS
Kondrashev
S Iu
SIu
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000818:Animals; D003131:Combined Modality Therapy; D004285:Dogs; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism; D005755:Gastrins / Q000097:blood / Q000187:drug effects; D005757:Gastritis, Atrophic / Q000097:blood / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008875:Middle Aged; D012970:Sodium Glutamate / Q000008:administration & dosage*; D013997:Time Factors
D005755:Gastrins; D012970:Sodium Glutamate
Primenenie odnozameshchennogo glutamata natriia v kompleksnoĭ terapii bol'nykh atroficheskim gastritom.